PP022 Establishment of an open standard for identification of HRD and patient susceptibility to PARPi

Autor: Korsholm, Lea Milling, Kjeldsen, Maj, Perino, Lorenzo, Mariani, Luca, Nyvang, Gitte-Bettina, Kristensen, Elisabeth, Bagger, Frederik Otzen, Mirza, Mansoor Raza, Rossing, Maria

Publikováno v: In ESMO Open December 2023 8(1) Supplement 6

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Beyond HRD status: Unraveling Genetic Variants Impacting PARP Inhibitor Sensitivity in Advanced Ovarian Cancer.

Autor: Kjeldsen MK; Rigshospitalet, Copenhagen, Denmark., Jørgensen M; Nordic Society of Gynecological Oncology (NSGO) and Rigshospitalet, Copenhagen University Hospital, Denmark., Grønseth DSB; Rigshospitalet, Denmark., Schønemann-Lund M; Odense University Hospital, Denmark., Nyvang GB; Odense University Hospital, Denmark., Haslund CA; Aalborg University Hospital, Aalborg, Denmark., Knudsen AO; Odense University Hospital, Odense, Denmark., Motavaf AK; Aalborg University Hospital, Denmark., Malander S; Institute of Clinical Sciences, Lund, Scania, Sweden., Anttila M; Kuopio University Hospital, Kuopio, Finland., Lindahl G; Linköping University Hospital, Linköping, Sweden., Mäenpää J; University of Tampere and Tampere University Hospital, Tampere, Finland., Dimoula M; Uppsala University Hospital, Sweden., Werner TL; University of Utah, Salt Lake City, UT, United States., Iversen TZ; Copenhagen University Hospital, Herlev, Herlev, Denmark., Hietanen S; Turku University Hospital, Turku, Finland., Fokdal L; Vejle Sygehus, Denmark., Dahlstrand H; Karolinska University Hospital, Sweden., Bjorge L; Haukeland University Hospital, Norway., Birrer MJ; University of Arkansas for Medical Sciences, Little Rock, AR, United States., Mirza MR; Rigshospitalet, Copenhagen, Denmark., Rossing M; Rigshospitalet, Copenhagen, Denmark.

Publikováno v: Cancer research communications [Cancer Res Commun] 2024 Nov 26. Date of Electronic Publication: 2024 Nov 26.